AzTrials
AzTrials

Breech PresentationTWEXITNCT04579835

Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)

An observational study of Breech Presentation and Twin; Complicating Pregnancy, run by Charite University, Berlin, Germany at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
External Cephalic Version
How many people
45 participants
Where
1 siteGermany
Study dates
28 Sep 2020to 28 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients presenting with Twin A breech presentation to the antenatal clinic

Who may be able to join

  • Presence of the written consent of the patients.
  • The patients must be over 18 years old .
  • No limit in the ability to consent.

Who cannot join

  • Age under 18
  • Limited ability to consent
  • Placenta previa
  • Fetal abnormalities

Trial locations and contacts

1 site in 1 country.

Larry Hinkson, FRCOG contact

004930450664710

Larry.Hinkson@charite.de

Germany1 site, 1 recruiting
  • Charité University Hospital

    Mitte, 10117

    Larry Hinkson, FRCOG

    Recruiting

Other trials in Germany

About this study

Official title: Twin A Breech External Cephalic Version Intervention Trial

A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy.

Read the detailed description

The primary goal of the study is to determine the success rate of Twin A external Cephalic Version in our obstetric clinic and to determine new favorable sonographic criteria associated with a successful attempt that have not been investigated before.

Being tested
External Cephalic Version
Medical subject headings
Breech Presentation, Pregnancy Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • External Cephalic VersionOther

    External Cephalic Version Twin A

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate of external cephalic version Twin A

    Mean Percentage (Range 0-100) - Successfully performed external cephalic Versions / Total number of participants

    Measured: 4 hours after external cephalic version

Secondary outcomes (10)
  1. Fetal weight

    Measurement in grams

    Measured: 30 Minutes before external cephalic version

  2. Fetal Doppler Umbilical Pulsatility Index

    Index mesurent /Ratio

    Measured: 30 Minutes before external cephalic version

  3. Fetal Doppler Umbilical Resistance Index

    Index mesurent /Ratio

    Measured: 30 Minutes before external cephalic version

  4. Incidence of pathological cardiotocogramm

    Numerical percentage

    Measured: 60 Minutes after external cephalic version

  5. Incidence of emergency delivery

    Numerical percentage

    Measured: 60 Minutes after external cephalic version

  6. Incidence of bleeding

    Numerical percentage

    Measured: 60 Minutes after external cephalic version

  7. Incidence of contractions

    Numerical percentage

    Measured: 60 Minutes after external cephalic version

  8. Incidence of rupture of membranes

    Numerical percentage

    Measured: 60 Minutes after external cephalic version

  9. Pain scores

    Numerical score: Pain scale Linkert score. (0-10 with 10 being extremely painful)

    Measured: 60 Minutes after external cephalic version

  10. Mode of Delivery

    Type of delivery (vaginal or caesarean)

    Measured: 6 weeks after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2020
  2. Study start28 Sep 2020
  3. Primary completion28 Sep 2025 (estimated)
  4. Study completion28 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04579835
Sponsor's protocol ID
EA2/116/20
Acronym
TWEXIT
Status last verified
Feb 2024
First submitted
28 Sep 2020
Last updated
6 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Breech Presentation and Twin; Complicating Pregnancy, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Larry Hinkson, FRCOG (004930450664710, Larry.Hinkson@charite.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate of external cephalic version Twin A (time frame: 4 hours after external cephalic version). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in